FC2Video

On its first quarter fiscal 2012 results, Synergetics USA Inc - SURG - posted sales of $13.5 million, a 12.0% increase year over year, and net income from continuing operations increased 81.3% to $1.2 million compared to the same period the prior year

Repros Therapeutics Incorporated - symbol RPRX - reported data from its recently completed ZA-204 study. The Oral Androxal Achieved Equivalent 24 Hour Average Testosterone Levels Compared to the leading FDA-approved topical gel used per manufacturer’s instructions